-transparent.png){kind=logo}
The insulinemic response to 1 g of tolbutamide i.v. is greatly enhanced (+ 145%) after a 60-min infusion of the alpha-lytic dihydrogenated ergot alkaloid, dihydroergocristine (83.3 micrograms/min, corresponding to a total dose of 5 mg) in 7 healthy subjects. No differences are observed in the glycemic responses.
Related Publications
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
November 1977,
Bollettino della Societa italiana di biologia sperimentale,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
November 1962,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
January 1977,
The Journal of clinical endocrinology and metabolism,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
September 1978,
Diabetologia,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
June 1990,
International journal of clinical pharmacology, therapy, and toxicology,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
April 1985,
Scottish medical journal,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
March 1975,
Il Farmaco; edizione pratica,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
May 1980,
Diabetes,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
June 1973,
Endocrinologia japonica,
F Caviezel, and
M Poli, and
A M Girardi, and
G Pozza
March 1973,
Acta endocrinologica,
